000 | 01621 a2200469 4500 | ||
---|---|---|---|
005 | 20250515173121.0 | ||
264 | 0 | _c20090914 | |
008 | 200909s 0 0 eng d | ||
022 | _a0027-5107 | ||
024 | 7 |
_a10.1016/j.mrgentox.2009.03.006 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aSantos, D B | |
245 | 0 | 0 |
_aGenotoxicity of organoselenium compounds in human leukocytes in vitro. _h[electronic resource] |
260 |
_bMutation research _cMay 2009 |
||
300 |
_a21-6 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 |
_aAntioxidants _xpharmacology |
650 | 0 | 4 |
_aBenzene Derivatives _xpharmacology |
650 | 0 | 4 |
_aCell Survival _xdrug effects |
650 | 0 | 4 | _aCells, Cultured |
650 | 0 | 4 |
_aDNA Damage _xdrug effects |
650 | 0 | 4 |
_aFree Radical Scavengers _xpharmacology |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aLeukocyte Count _xmethods |
650 | 0 | 4 |
_aLeukocytes _xdrug effects |
650 | 0 | 4 |
_aMutagenicity Tests _xstandards |
650 | 0 | 4 |
_aOrganoselenium Compounds _xpharmacology |
650 | 0 | 4 |
_aOxidative Stress _xdrug effects |
650 | 0 | 4 |
_aReactive Oxygen Species _xpharmacology |
650 | 0 | 4 |
_aSelenium Compounds _xpharmacology |
700 | 1 | _aSchiar, V P P | |
700 | 1 | _aRibeiro, M C P | |
700 | 1 | _aSchwab, R S | |
700 | 1 | _aMeinerz, D F | |
700 | 1 | _aAllebrandt, J | |
700 | 1 | _aRocha, J B T | |
700 | 1 | _aNogueira, C W | |
700 | 1 | _aAschner, M | |
700 | 1 | _aBarbosa, N B V | |
773 | 0 |
_tMutation research _gvol. 676 _gno. 1-2 _gp. 21-6 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.mrgentox.2009.03.006 _zAvailable from publisher's website |
999 |
_c18911675 _d18911675 |